Regorafenib Hydrate CAS 1019206-88-2

China Regorafenib Hydrate Suppliers

Regorafenib Hydrate is a hydrate that is the monohydrate form of anhydrous regorafenib. Used for for the treatment of metastatic colorectal cancer in patients who have previously received chemotherapy, anti-EGFR or anti-VEGF therapy. It has a role as an antineoplastic agent, a tyrosine kinase inhibitor and a hepatotoxic agent. It contains a regorafenib.

Regorafenib is an oral multi-kinase inhibitor that is used in the therapy of refractory metastatic colorectal cancer, hepatocellular carcinoma and gastrointestinal stromal tumor. Regorafenib has been associated with frequent serum aminotransferase elevations during therapy and with rare, but sometimes severe and even fatal instances of clinically apparent liver injury.

Regorafenib is a pyridinecarboxamide obtained by condensation of 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]pyridine-2-carboxylic acid with methylamine. Used for for the treatment of metastatic colorectal cancer in patients who have previously received chemotherapy, anti-EGFR or anti-VEGF therapy. It has a role as an antineoplastic agent, a tyrosine kinase inhibitor and a hepatotoxic agent. It is an aromatic ether, a pyridinecarboxamide, a member of monochlorobenzenes, a member of (trifluoromethyl)benzenes, a member of monofluorobenzenes and a member of phenylureas.

Regorafenib Hydrate CAS 1019206-88-2,Regorafenib Hydrate CAS 1019206-88-2,BAY 73-4506 CAS 1019206-88-2,High Quality Regorafenib Monohydrate offering.

Regorafenib Hydrate

Top Quality Best Price Regorafenib monohydrate (BAY 73-4506)

Pharmaceutical Raw Material regorafenib hydrate

Top Quality Best Price Regorafenib monohydrate (BAY 73-4506)

Pharmaceutical Raw Material regorafenib hydrate

China Regorafenib Hydrate Suppliers